Healthcare - Biotechnology - NASDAQ - US
$ 13.83
-3.49 %
$ 200 M
Market Cap
0.12
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
272.55%
EBIT
Estimate
--12.15%
Net Income
Estimate
9.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Inhibrx Biosciences, Inc.
INBX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart INBX
EBIT FORECAST
EBIT Forecast Chart INBX
NET INCOME FORECAST
Net Income Chart INBX